Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Provan

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|December 23, 2016
The diagnosis and management of primary autoimmune haemolytic anaemiaQuentin A Hill, Robert Stamps, Edwin Massey, et al.
Haematologica|December 7, 2007
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adultsDrew Provan, Tom Butler, Maria Laura Evangelista, et al.
British Journal of Haematology|April 4, 2017
Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemiaQuentin A Hill, Robert Stamps, Edwin Massey, et al.
The Oncologist|August 5, 2005
Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concernsRoberto Stasi, Sergio Amadori, Timothy J Littlewood, et al.
British Journal of Haematology|October 19, 2010
Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP RegistryAmeet Sarpatwari, Drew Provan, Sebhat Erqou, et al.
Blood Vessels, Thrombosis & Hemostasis|February 3, 2026
Inflammatory cytokines, inflammasomes, and neutrophil extracellular traps in primary immune thrombocytopenia pathogenesisAlessandro Lucchesi, Maria Belen Rodriguez, Matias Cordoba, et al.
International Journal of Hematology|July 24, 2015
Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostimDouglas B Cines, Terry Gernsheimer, Jeffrey Wasser, et al.
Blood|August 1, 2002
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch eventsSurinder S Sahota, Francesco Forconi, Christian H Ottensmeier, et al.
British Journal of Haematology|March 11, 2015
United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findingsHasan Rizvi, Tom Butler, Mariarita Calaminici, et al.
Haematologica|February 11, 2010
Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research DatabaseAmeet Sarpatwari, Dimitri Bennett, John W Logie, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|December 23, 2016
The diagnosis and management of primary autoimmune haemolytic anaemiaQuentin A Hill, Robert Stamps, Edwin Massey, et al.
Haematologica|December 7, 2007
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adultsDrew Provan, Tom Butler, Maria Laura Evangelista, et al.
British Journal of Haematology|April 4, 2017
Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemiaQuentin A Hill, Robert Stamps, Edwin Massey, et al.
The Oncologist|August 5, 2005
Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concernsRoberto Stasi, Sergio Amadori, Timothy J Littlewood, et al.
British Journal of Haematology|October 19, 2010
Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP RegistryAmeet Sarpatwari, Drew Provan, Sebhat Erqou, et al.
Blood Vessels, Thrombosis & Hemostasis|February 3, 2026
Inflammatory cytokines, inflammasomes, and neutrophil extracellular traps in primary immune thrombocytopenia pathogenesisAlessandro Lucchesi, Maria Belen Rodriguez, Matias Cordoba, et al.
International Journal of Hematology|July 24, 2015
Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostimDouglas B Cines, Terry Gernsheimer, Jeffrey Wasser, et al.
Blood|August 1, 2002
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch eventsSurinder S Sahota, Francesco Forconi, Christian H Ottensmeier, et al.
British Journal of Haematology|March 11, 2015
United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findingsHasan Rizvi, Tom Butler, Mariarita Calaminici, et al.
Haematologica|February 11, 2010
Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research DatabaseAmeet Sarpatwari, Dimitri Bennett, John W Logie, et al.
Pageof 9